ERBB2 and lung carcinoma: To test HER2 expression in lung cancer, 14 nonsmall cell lung adenocarcinoma (NSCLAC), 12 NSCL squamous cell cancer (NSCLSC), and five SCL cancer (SCLC) samples were obtained and immunostained with HER2 antibodies.